MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Pacira Pharmaceuticals Company Profile (NASDAQ:PCRX)

Consensus Ratings for Pacira Pharmaceuticals (NASDAQ:PCRX) (?)
Ratings Breakdown: 1 Sell Rating(s), 1 Hold Rating(s), 6 Buy Rating(s)
Consensus Rating:Buy (Score: 2.63)
Consensus Price Target: $105.67 (51.95% upside)

Current Analysts' Coverage Summary for Pacira Pharmaceuticals (NASDAQ:PCRX)
Show:
DateFirmActionRatingPrice TargetActions
6/25/2015WedbushReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/19/2015Leerink SwannInitiated CoverageMarket Perform$86.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/28/2015Brean CapitalReiterated RatingBuy$92.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/9/2015Jefferies GroupReiterated RatingBuy$113.00 -> $81.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/30/2015Canaccord GenuityLower Price TargetBuy$128.00 -> $89.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/3/2015BarclaysLower Price TargetOverweight$127.00 -> $115.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/26/2015Bank of AmericaDowngradeNeutral -> Underperform$112.00 -> $110.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/25/2015Piper JaffraySet Price TargetBuy$136.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/30/2015Goldman SachsBoost Price Target$126.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/17/2014JMP SecuritiesInitiated CoverageMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/18/2014National Alliance SecuritiesInitiated CoverageBuy$109.41View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/6/2013 forward)